EP4339615
AND-PD-1 MÓTEFNI TIL NOTKUNAR Í MEÐFERÐ VIÐ KRABBA
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
9.9.2017EP published:
5.11.2025EP application number:
24150762.3
EP translation filed:
4.12.2025Grant published:
14.1.2026EPO information:
European Patent Register
Max expiry date:
8.9.2037Expiry date:
8.9.2026
Title in English:
ANTI-PD-1 ANTIBODIES FOR USE IN THE TREATMENT OF CANCERLanguage of the patent:
English
Timeline
Today
9.9.2017EP application
5.11.2025EP Publication
4.12.2025Translation submitted
14.1.2026Registration published
8.9.2026Expires
Owner
Name:
Shanghai Henlius Biotech, Inc.Address:
Room 303, 304, Block 7 No. 1999 Zhangheng Road Pilot Free Trade Zone, Shanghai, CN
Inventor
Name:
JIANG, WeidongAddress:
Shanghai, CN
Name:
LIN, Pei-HuaAddress:
Shanghai, CN
Name:
TSENG, Chi-LingAddress:
Shanghai, CN
Agent
Name:
Bergenstråhle & Lindvall ABAddress:
P.O. Box 17704, Ringvägen 100, SE
Priority
Number:
201662395832 PDate:
16.9.2016Country:
US
Number:
201762519590 PDate:
14.6.2017Country:
US
Supplementary protection
SPC number:
SPC534
Classification
Categories:
C07K 16/28, C07K 16/22, C07K 16/18, A61K 39/395, A61K 47/68, A61K 49/16, A61K 51/10, A61P 35/00, C12P 21/08